JY09

· Beijing Dongfang Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for JY09, covering 2016-12-07 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients [Phase 3]